Liquid Biopsy Research Tools, Services and Diagnostics Global Markets

1

• Global Markets on Liquid Biopsy Research Tools,
  Services and Diagnostics

2
The global liquid biopsy market should reach
nearly 4.5 billion in 2020 from 1.6 billion in
2015, registering a CAGR of 22.3 for the period
of 2015-2020. This report provides -An overview
of the global markets for liquid biopsy research
tools, services, and diagnostics -Analyses of
global market trends, with data for 2014,
estimates for 2015, and projections of CAGRs
through 2020 -Coverage of how these technologies
can reduce invasive tumor biopsies, drive early
cancer detection, and support precise drug
administration -Detailed analysis of liquid
biopsy workflow technologies, biomarker classes,
sample types, research tools reagents, and more
3
-Breakdowns of the market by product, product
type, application, end use industry, technology,
indication, as well as many others -Evaluation of
the market's dynamics, specifically growth
drivers, restraints, and opportunities -Profiles
of major players in the industry INTRODUCTION STU
DY GOALS AND OBJECTIVES This Research report
provides an in-depth study of the liquid biopsy
diagnostics industry, an emerging industry with
high market potential. The global market is
analyzed by application, biomarker type, analysis
platform, analysis purpose and geographic region.
The market sizes are given for the years 2014,
2015 and 2020. Market segments that provide
exceptional growth opportunities include cancer
monitoring and organ transplant surveillance.
4
The report provides a comprehensive discussion of
liquid biopsy technologies, clinical
applications, industry structure, important
liquid biopsy funding initiatives, global
markets, patent status and companies. The report
is designed to aid companies in their strategic
planning efforts relating to life science tools
and diagnostics. REASONS FOR DOING THE
STUDY Traditional biopsy methods are often
invasive and uncomfortable, and carry risks of
side effects. Liquid biopsy addresses these
issues because it is noninvasive and carries
little, if any, side effect risks. With the
advent of the age of genomics and personalized
medicine, it is critical for clinicians to have
diagnostic tools that can be used on a regular
basis to monitor, conduct surveillance, guide
treatment or otherwise give valuable genomic
information about a disease. Liquid biopsy
provides this capability, and thus is of high
interest to the medical community.
5
Liquid biopsy enabling technologies are rapidly
making progress, and this is adding to the market
growth momentum. Downstream analysis technologies
like next-generation sequencing (NGS) and digital
polymerase chain reaction (PCR) are progressing
in capabilities, efficiency and costs. Upstream
technologies like microfluidics, cell capture and
DNA amplification are also making significant
progress. Based on these trends, liquid biopsy
markets are rapidly emerging, and the need for
industry and market characterization is
great. Also, liquid biopsy is extending its
market penetration into high-volume diagnostics
segments, including average risk noninvasive
prenatal testing (NIPT) and cancer
monitoring. The outstanding growth potential for
liquid biopsy diagnostics makes it particularly
timely for doing this report.
6
SCOPE AND FORMAT The scope of the report includes
liquid biopsy technologies, applications,
industry subsegments, biomarker technologies,
major funding initiatives, patents and companies.
The market sizes for liquid biopsy diagnostics
are given for 2014, 2015 and 2020. This report
reviews liquid biopsy biomarkers and
technologies, and provides background on why
liquid biopsy is advantageous versus tissue
biopsy. It then discusses some of the top
research initiatives that are contributing to
liquid biopsy development. Market driving forces
are also discussed. The structure of several
important industry subsectors are reviewed, as
well as major industry acquisitions and strategic
alliances from 2013 to the present. Industry
subsectors analyzed include NGS instruments,
droplet digital PCR, target enrichment and
amplification, single cell DNA polymerase,
noninvasive prenatal screening and general liquid
biopsy.
7
METHODOLOGY Both primary and secondary research
methodologies were used in preparing this study.
Research examined each of the key end-user market
segments that will be commercially important
during the next five years reproductive health,
cancer and organ transplantation. Based on this
analysis, the current and future applications of
liquid biopsy diagnostics are evaluated in each
of the major market segments, and sales revenues
are forecast for 2015 through 2020. Based on
analysis of both secondary and primary market
sources, as well as the key trends in the
industry, the report provides the current and
projected market size for the various liquid
biopsy market segments for the years 2014, 2015
and 2020.
8
INFORMATION SOURCES This Report Research
performed both primary and secondary research for
this report. Primary sources included key
industry companies and leading research
institutions. In addition, data were compiled
from secondary sources, including company
websites and industry, trade and government
publications.
9
Table of Contents

1. Introduction - Complimentary 4 0
2. Executive Summary 3 250
3. Overview 6 327
4. Technologies 18 981
5. Liquid Biopsy Initiatives 4 218
6. Liquid Biopsy Applications 8 436
7. Liquid Biopsy Industry 25 1363
8. Acquisitions And Strategic Alliances 12 654
9. Markets 34 1853
10. Patents 2 109

W www.bharatbook.com , T  91 22 27810772,
27810773, E  info_at_bharatbook.com
10
To view the full Executive Summary and Table
of Contents, please visit Global Markets on
Liquid Biopsy Research Tools, Services and
Diagnostics Contact Us-Call India
91-22-27810772/73Email id poonam_at_bharatbook.co
mWebsite www.bharatbook.comOur Blog
https//www.bharatbook.com/blog/

W www.bharatbook.com , T  91 22 27810772,
27810773, E  poonam_at_bharatbook.com